This May Be the Best News in Pfizer's Earnings Report

Pfizer (NYSE: PFE) delivered plenty of good news in its first-quarter earnings report this week. The company raised its 2021 sales forecast for its coronavirus vaccine by 73%. Pfizer also lifted its annual revenue guidance -- and raised guidance excluding coronavirus vaccine sales. Investors looking for income should be happy too: Pfizer is maintaining its dividend level even after Viatris -- the result of its Upjohn spinoff -- begins paying one.

Among all of these positive points, though, one particular item stands out. Here are two clues. One: It has to do with the company's coronavirus vaccine. Two: It has to do with ensuring future revenue. And the item is...

Image source: Getty Images.

Continue reading

Source Fool.com